Pharmacokinetics and dosimetry of iodine-123 labelled PE2I in humans, a radioligand for dopamine transporter imaging

European Journal of Nuclear Medicine

Volumn 25, Issue 5, 1998, Pages 531-534

  Kuikka, Jyrki T ^a   Baulieu, Jean L ^b   Hiltunen, Jukka ^c   Halldin, Christer ^d   Bergström, Kim A ^a   Farde, Lars ^d   Emond, Patrik ^b   Chalon, Sylvie ^b   Yu, Meixiang ^a   Nikula, Tuomo ^c   Laitinen, Tomi ^a   Karhu, Jari ^a   Tupala, Erkki ^e   Hallikainen, Tero ^e   Kolehmainen, Ville ^f   Mauclaire, Laurent ^g   Maziere, Bernard ^h   Tiihonen, Jari ^e   Guilloteau, Denis ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UNIVERSITÉ DE TOURS   (France)

^c MAP Medical Technologies Oy   (Finland)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e Niuvanniemen sairaala   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g CIS Bio International   (France)

^h DIF   (France)

Author keywords

Dopamine transporter; Human brain; Single photon emission tomography; Striatum

Indexed keywords

DOPAMINE TRANSPORTER; IODINE 123; PE21; RADIOLIGAND; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRAIN; CORPUS STRIATUM; FEMALE; HUMAN; HYPOTHALAMUS; INTERMETHOD COMPARISON; MALE; MESENCEPHALON; NORMAL HUMAN; PHARMACOKINETICS; RADIOACTIVITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 15144360264     PISSN: 03406997     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002590050254     Document Type: Article

References (11)

1. 11C]β-CIT binding to monoamine transporters in the monkey and human brain. Synapse 1994; 16: 93-103.
2. 123I]β-CIT-FP. Parkinsonism and Related Disorders 1997; 3: 77-81.
3. Kuikka JT, Åkerman K, Bergström KA, et al. Iodine-123 labelled N-(2-fluoroethyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane for dopamine trans-porter imaging in the living brain. Eur J Nucl Med 1995; 22: 682-686.
4. Edmond P, Garreau L, Chalon S, et al. Synthesis and ligand binding of nortropane derviatives: N-substituted-2β-carbomethoxy-3β-(4-iodophenyl)nortropane and N-(3-iodoprop-2E-enyl)-2β-carbomethoxy-3β-(3′,4*- disubstituted phenyl)nortropane. New high affinity and selective compounds for the dopamine transporter. J Med Chem 1997; 40: 1366-1372.
5. 125-I]PE2I [abstract]. Eur J Nucl Med 1997; 24: 880.
6. Guilloteau D, Emond P, Baulieu JL, et al. Exploration of the dopamine transporter: in vitro and in vivo characterization of high affinity and high specificity iodinated tropane derivative (E)-N-(3-iodoprop-2-enyl)-2β-carbomethoxy-3β-(4′-methylphenyl) nortropane or PE2I. Nucl Med Biol 1998; 25: (in press).
7. Halldin C, Lundkvist C, Guilloteau D, et al. The first selective dopamine transporter radioligand suitable for quantitation with PET and SPET [abstract]. Eur J Nucl Med 1997; 24: 1057.
8. Bergström KA, Halldin C, Lundkvist C, et al. Characterization of C-11 or I-123 labelled β-CIT-FP and β-CIT-FE metabolism measured in monkey and human plasma. Identification of two labelled metabolites with HPLC. Hum Psychopharmacol 1996; 11: 483-490.
9. Ciliax BJ, Heilman C, Demchyshyn LL, et al. The dopamine transporter: immunochemical characterization and localization in brain. J Neurosci 1995; 15: 1714-1723.
10. Goodman MM, Kung MP, Kabalka GW, Kung HF, Switzer R. Synthesis and characterization of radioiodinated N-(3-iodopropen-1-yl)-2β-carbomethoxy-3β-(4-chlorophenyl)tropanes: potential dopamine reuptake site imaging agents. J Med Chem 1994; 37: 1535-1542.
11. Kung HF, Kim HJ, Kung MP, et al. Imaging of dopamine transporters in humans with technetium-99m TRODAT-I. Eur J Nucl Med 1996; 23: 1527-1530.